JMAR Builds out Operations and Manufacturing Center; Doug Cheng Appointed VP of Operations, Will...

SAN DIEGO -- JMAR Technologies, Inc. (NASDAQ: JMAR) is expanding its Operations and Manufacturing Center, based in Burlington, Vermont, to meet the manufacturing, engineering and production requirements of the Company's emerging product portfolio. JMAR has appointed Doug Cheng, a seasoned executive

As Vice President of Operations, Mr. Cheng will assume the day-to-day management of JMAR's Vermont-based production activities from Dan Fleming, General Manager, who has directed the Systems Division's X-ray lithography development work.

Mr. Cheng's initial focus will be initiating concurrent engineering and preparing for the impending manufacture of BioSentry(TM), a laser-based, early-warning system for detecting and classifying potentially harmful microorganisms in water supplies. This real-time monitoring system, with potential applications for water utility operations, beverage bottling, homeland security and critical facility maintenance, is scheduled to ramp up to full-scale production in mid-2005.

Mr. Cheng brings to JMAR his previous experience in key management and engineering roles at Phillips Automotive Electronics, where he rose to the position of general manager, assuming responsibility for operations, engineering and finance, and a 14-year tenure at General Electric that encompassed several progressive manufacturing management and engineering positions. More recently, Mr. Cheng served as Plant Manager of Dynapower Corporation, where he oversaw manufacturing, production planning and product testing of the company's industrial and research oriented products. Cheng holds an engineering degree from the University of Vermont.

"The build out of the Operations and Manufacturing Center and the hire of Doug Cheng are critical steps in the execution of our plan for commercialization of JMAR's core technologies," says Ronald A. Walrod, CEO of JMAR. "Doug's demonstrated ability to build and manage effective manufacturing organizations suits JMAR's immediate needs as we prepare to meet international demand for our new products. His experience as the general manager of a vertically integrated business unit with annual revenues in excess of $100 million positions him as a key contributor to JMAR's growth oriented management team."

The Operations and Manufacturing Center will work in conjunction with the Systems Division Programs team, also based in Burlington, Vermont, which holds the primary responsibility for securing government research and development funding, and developing new products from its core precision alignment and positioning technology.

About JMAR

JMAR Technologies, Inc. is a leading innovator in the development of laser-based equipment for imaging, analysis and fabrication at the nano-scale. The Company is leveraging over a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries while continuing to provide support for the U.S. Government's Defense Microelectronics Activity (DMEA) semiconductor fabrication facility. JMAR is targeting the nanotech, bioscience and semiconductor industries with its Britelight(TM) laser; Compact X-ray Light Source; X-ray Microscope - for 3D visualization of single cells and polymers; and its X-ray Nano Probe - enabling interaction, analysis and modification at the nano-scale. JMAR also maintains strategic alliances for the development of BioSentry(TM) and READ - biological and chemical sensors for homeland security, environmental and utility infrastructure industries.

This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including delays in completion of the BioSentry and other new product prototypes and transition to production units, the risk that the acquisition of The LXT Group will not occur due to failure to achieve agreed upon development milestones or budgeted costs, the possibility of infringement of issued patents, the failure of new product technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the market, cost and margins, failure to obtain market acceptance, current or future government regulations affecting the use of BioSentry products, the lack of availability of critical components, the degree of protection from future patents, and other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's 2003 Form 10-K filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.